Relief of idiopathic subjective tinnitus: Is gabapentin effective?

Archives of Otolaryngology - Head and Neck Surgery

Volumn 133, Issue 4, 2007, Pages 390-397

  Piccirillo, Jay F ^a   Finnell, Joshua ^a   Vlahiotis, Anna ^a   Chole, Richard A ^a   Spitznagel Jr , Edward ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; LACTOSE; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; OTORHINOLARYNGOLOGY; RANDOMIZED CONTROLLED TRIAL; TINNITUS;

ADOLESCENT; ADULT; AGED; AMINES; CALCIUM CHANNEL BLOCKERS; CHI-SQUARE DISTRIBUTION; CYCLOHEXANECARBOXYLIC ACIDS; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; TINNITUS; TREATMENT OUTCOME;

EID: 34247372983     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.133.4.390     Document Type: Article

References (32)

1. Seidman MD, Jacobson GP. Update on tinnitus. Otolaryngol Clin North Am. 1996;29:455-465.
2. Davis A, Rafaie A. Epidemiology of tinnitus. In: Tyler RS, ed. Tinnitus Handbook. San Diego, Calif: Singular Publishing Group; 2000:1-24.
3. Lenarz T, Schreiner C, Snyder RL, Ernst A. Neural mechanisms of tinnitus. Eur Arch Otorhinolaryngol. 1993;249:441-446.
4. Lockwood AH, Salvi RJ, Burkard RF, Galantowicz PJ, Coad ML, Wack DS. Neuroanatomy of tinnitus. Scand Audiol Suppl. 1999;51:47-52.
5. Kaltenbach JA. Neurophysiologic mechanisms of tinnitus. J Am Acad Audiol. 2000;11:125-137.
6. Lockwood AH, Salvi RJ, Burkard RF. Tinnitus. N Engl J Med. 2002;347:904-910.
7. Tonndorf J. The analogy between tinnitus and pain: a suggestion for a physiological basis of chronic tinnitus. Hear Res. 1987;28:271-275.
8. Moller AR. Similarities between severe tinnitus and chronic pain. J Am Acad Audiol. 2000;11:115-124.
9. Folmer RL, Griest SE, Martin WH. Chronic tinnitus as phantom auditory pain. Otolaryngol Head Neck Surg. 2001;124:394-400.
10. Zapp JJ. Gabapentin for the treatment of tinnitus: a case report. Ear Nose Throat J. 2001;80:114-116.
11. Bauer CA, Brozoski TJ. Effect of gabapentin on the sensation and impact of tinnitus. Laryngoscope. 2006;116:675-681.
12. Kuk FK, Tyler RS, Russell D, et al. The psychometric properties of a tinnitus handicap questionnaire. Ear Hear. 1990;11:434-445.
13. Newman CW, Jacobson GP, Spitzer JB. Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg. 1996;122:143-148.
14. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983;13:595-605.
15. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
16. Meikle MB, Vernon J, Johnson RM. The perceived severity of tinnitus: some observations concerning a large population of tinnitus clinic patients. Otolaryngol Head Neck Surg. 1984;92:689-696.
17. Baskill JL, Coles RRA. Relationships between tinnitus loudness and severity. In: Hazell JW, ed. Proceedings of the Sixth International Tinnitus Seminar. London, England: Tinnitus and Hyperacusis Centre; 2002:424-428.
18. Newman CW, Sandridge SA, Jacobson GP. Psychometric adequacy of the Tinnitus Handicap Inventory (THI) for evaluating treatment outcome. J Am Acad Audiol. 1998;9:153-160.
19. Simpson JJ, Davies WE. Recent advances in the pharmacological treatment of tinnitus. Trends Pharmacol Sci. 1999;20:12-18.
20. Jastreboff PJ, Jastreboff MM. Tinnitus retraining therapy (TRT) as a method for treatment of tinnitus and hyperacusis patients. J Am Acad Audiol. 2000;11:162-177.
21. Jastreboff PJ. Phantom auditory perception (tinnitus): mechanisms of generation and perception. Neurosci Res. 1990;8:221-254.
22. Jastreboff PJ, Hazell JW. A neurophysiological approach to tinnitus: clinical implications. Br J Audiol. 1993;27:7-17.
23. Bartnik G, Fabijanska A, Rogowski M. Effects of tinnitus retraining therapy (TRT) for patients with tinnitus and subjective hearing loss versus tinnitus only. Scand Audiol Suppl. 2001;(52):206-208.
24. Andersson G, Lyttkens L. A meta-analytic review of psychological treatments for tinnitus. Br J Audiol. 1999;33:201-210.
25. Dobie RA. A review of randomized clinical trials in tinnitus [review]. Laryngoscope. 1999;109:1202-1211.
26. Dobie RA, Sakai CS, Sullivan MD, Katon WJ, Russo J. Antidepressant treatment of tinnitus patients: report of a randomized clinical trial and clinical prediction of benefit. Am J Otol. 1993;14:18-23.
27. Bayar N, Boke B, Turan E, Belgin E. Efficacy of amitriptyline in the treatment of subjective tinnitus. J Otolaryngol. 2001;30:300-303.
28. Xiao WH, Bennett GJ. Gabapentin relieves abnormal pain in a rat model of painful peripheral neuropathy. Soc Neurosci Abstracts. 1995;21:897.
29. Attal N, Brasseur L, Parker F, Chauvin M, Bouhassira D. Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: a pilot study. Eur Neurol. 1998;40:191-200.
30. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998;280:1831-1836.
31. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998;280:1837-1842.
32. Bauer CA, Brozoski TJ. Assessing tinnitus and prospective tinnitus therapeutics using a psychophysical animal model. J Assoc Res Otolaryngol. 2001;2:54-64.